Bright Minds Biosciences DRUG
NASDAQ DRUG
$50.44 -4.76 (-8.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Bright Minds Biosciences (DRUG) Operating Income (2023 - 2024)

Updated

Analysis

Bright Minds Biosciences (DRUG) Operating Income (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 11.75 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 7.14 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 6.43 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -584.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 4.75 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 3.16 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 3.51 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -10.39 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 4.27 Bn
10 Bright Minds Biosciences 343.90 Mn -219.69 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 32,422.24
Jun 30, 2024 157,133.80
Dec 31, 2023 -1.24 Mn
Jun 30, 2023 -1.09 Mn
API Access

Bright Minds Biosciences Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=DRUG&period=max&api_key=YOUR_API_KEY